Phosphopeptide Binding Specificities of BRCA1 COOH-terminal (BRCT) Domains
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Protein phosphorylation by protein kinases may generate docking sites for other proteins. It thus allows the assembly of signaling complexes in response to kinase activation. Several protein domains that bind phosphoserine or phosphothreonine residues have been identified, including the 14-3-3, PIN1, FHA, KIX, WD-40 domain, and polo box (Yaffe, M. B., and Elia, A. E. (2001) Curr. Opin. Cell Biol. 13, 131-138; Elia, A. E., Cantley, L. C., and Yaffe, M. B. (2003) Science 299, 1228-1231). The BRCA1 COOH-terminal (BRCT) domains are protein modules found in many proteins that regulate DNA damage responses (Koonin, E. V., Altschul, S. F., and Bork, P. (1996) Nat. Genet. 13, 266-268). Whether BRCT domains can mediate phosphorylation-dependent interactions has not been systematically investigated. We report here that the BRCT domains also recognize phosphopeptides. Oriented peptide library analysis indicated that the BRCT domains from BRCA1, MDC1, BARD1, and DNA Ligase IV preferred distinct phosphoserine-containing peptides. In addition, the interaction between BRCA1 and the BRCT binding motif of BACH1 was required for BACH1 checkpoint activity. Furthermore, BRCT domains of the yeast DNA repair protein Rad9 could bind phosphopeptides, suggesting that the BRCT domains represent a class of ancient phosphopeptide-binding modules. Potential targets of BRCT domains were identified through data base search. Structural analysis of BRCA1 BRCT repeats also predicted conserved residues that may form the phosphopeptide-binding pocket. Thus, the BRCT repeats are a new family of phosphopeptide-binding domains in DNA damage responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The C-terminal BRCT domains of BRCA1 constitute a phospho-peptide recognition domain that binds specifically to phospho-peptides containing a pSPxF (phosphor-serine-proline-x-phenylalanine) motif (Manke et al., 2003; Rodriguez et al., 2003; Yu et al., 2003).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Rodriguez et al., 2003
In the citing paper
“Structural and biochemical analysis of BRCA1 BRCT domains bound to optimized phosphopeptides has revealed that the phenylalanine residue in the pSPxF motif is essential for the recognition of this motif by the BRCT domains (Rodriguez et al., 2003; Shiozaki et al., 2004; Williams et al., 2004).”
From The BRCA1-Interacting Protein Abraxas Is Required for Genomic Stability and Tumor Suppression (2014) · cites this paper as Rodriguez et al., 2003
Citations
Cites
SH2 domains recognize specific phosphopeptide sequences
Zhou, S. (1993) · Cell · doi:10.1016/0092-8674(93)90404-e · Cited by 2,631
Self-citationDNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Signaling Through Scaffold, Anchoring, and Adaptor Proteins
Pawson, T., & Scott, J. D. (1997) · Science · doi:10.1126/science.278.5346.2075 · Cited by 2,256
MDC1 is a mediator of the mammalian DNA damage checkpoint
Stewart, G. S., Wang, B., Bignell, C. R., Taylor, A. M. R., & Elledge, S. J. (2003) · Nature · doi:10.1038/nature01446 · Cited by 874
The BRCT Domain Is a Phospho-Protein Binding Domain
Yu, X., Chini, C. C. S., He, M., Mer, G., & Chen, J. (2003) · Science · doi:10.1126/science.1088753 · Cited by 862
Self-citationA superfamily of conserved domains in DNA damage‐ responsive cell cycle checkpoint proteins
Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., & Koonin, E. V. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.1.9034168 · Cited by 746
Identification of a RING protein that can interact in vivo with the BRCA1 gene product
Wu, L. C., Wang, Z. W., Tsan, J. T., Spillman, M. A., Phung, A., Xu, X. L., Yang, M.-C. W., Hwang, L.-Y., Bowcock, A. M., & Baer, R. (1996) · Nature Genetics · doi:10.1038/ng1296-430 · Cited by 746
Frank, R. (2002) · Journal of Immunological Methods · doi:10.1016/s0022-1759(02)00137-0 · Cited by 741
Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to Mitotic Substrates
Elia, A. E. H., Cantley, L. C., & Yaffe, M. B. (2003) · Science · doi:10.1126/science.1079079 · Cited by 684
Cantor, S. B., Bell, D. W., Ganesan, S., Kass, E. M., Drapkin, R., Grossman, S., Wahrer, D. C. R., Sgroi, D. C., Lane, W. S., Haber, D. A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00304-x · Cited by 674
Research works printed but not linked: 2
- Caldecott, 1994, Mol. Cell. Biol., 14, 68
- Weinert, 1990, Mol. Cell. Biol., 10, 6554
Cited by
-H2AX in recognition and signaling of DNA double-strand breaks in the context of chromatin
Kinner, A., Wu, W., Staudt, C., & Iliakis, G. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn550 · Cited by 1,256
“73 143 HUMAN (73) DNKKTRIIPRHLQLAIRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTSATVGPKAPSGGKKATQASQEY MOUSE (73) DNKKTRIIPRHLQLAIRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKSSATVGPKAPAVGKKASQASQEY XENLA (73) DNKKSRIIPRHLQLAVRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKSSGGVSTSG----KKSSQQSQEY DANRE (73) DNKKTRIIPRHLQLAVRNDEELNKLLGGVTIAQGGVLPNIQAVLLPKKTGQA…”
BackgroundStucki, M., Clapperton, J. A., Mohammad, D., Yaffe, M. B., Smerdon, S. J., & Jackson, S. P. (2005) · Cell · doi:10.1016/j.cell.2005.09.038 · Cited by 1,099
Abraxas and RAP80 Form a BRCA1 Protein Complex Required for the DNA Damage Response
Wang, B., Matsuoka, S., Ballif, B. A., Zhang, D., Smogorzewska, A., Gygi, S. P., & Elledge, S. J. (2007) · Science · doi:10.1126/science.1139476 · Cited by 695
Lou, Z., Minter-Dykhouse, K., Franco, S., Gostissa, M., Rivera, M. A., Celeste, A., Manis, J. P., van Deursen, J., Nussenzweig, A., Paull, T. T., et al. (2006) · Molecular Cell · doi:10.1016/j.molcel.2005.11.025 · Cited by 628
Self-citationH2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy
Podhorecka, M., Skladanowski, A., & Bozko, P. (2010) · Journal of Nucleic Acids · doi:10.4061/2010/920161 · Cited by 612
“It was shown that the BRCT repeats of mediator of DNA damage checkpoint protein 1 (MDC1) build the predominant recognition module of γH2AX [39, 43, 54, 55].”
BackgroundCrosstalk between histone modifications during the DNA damage response
van Attikum, H., & Gasser, S. M. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.03.001 · Cited by 519
DNA damage-induced activation of ATM and ATM-dependent signaling pathways
Kurz, E. U., & Lees-Miller, S. P. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.029 · Cited by 478
The Fanconi Anemia/BRCA pathway: new faces in the crowd
Kennedy, R. D., & D'Andrea, A. D. (2005) · Genes & Development · doi:10.1101/gad.1370505 · Cited by 467
“BRIP1 is phosphorylated and associates with the BRCA1 C Terminus (BRCT) motifs of BRCA1 during S phase of the cell cycle (Rodriguez et al. 2003; Yu et al. 2003).”
BackgroundWang, B., & Elledge, S. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710061104 · Cited by 445
Invited Review: Bovine Milk Fat Globule Membrane as a Potential Nutraceutical
Spitsberg, V. L. (2005) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(05)72906-4 · Cited by 419
“The C-terminal domain (BRCT) of the both BRCA1 proteins, human and bovine, has a similar activity in binding the phosphopeptides important in DNA damage responses (Krum et al., 2003; Rodriguez et al., 2003).”
BackgroundγH2AX and MDC1: Anchoring the DNA-damage-response machinery to broken chromosomes
Stucki, M., & Jackson, S. P. (2006) · DNA Repair · doi:10.1016/j.dnarep.2006.01.012 · Cited by 412
Yu, X., & Chen, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9478-9486.2004 · Cited by 410
“Recent biochemical studies demonstrated that the BRCA1 BRCT domains are a phospho-protein binding motif (18, 19, 38).”
BackgroundSelf-citationThompson, L. H. (2012) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2012.06.002 · Cited by 357
Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation
Li, M., & Yu, X. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.025 · Cited by 321
“A previous study suggests that the BARD1 BRCT may selectively recognize the pSDDE motif (Rodriguez et al., 2003).”
BackgroundSelf-citationMHAWECH, P. (2005) · Cell Research · doi:10.1038/sj.cr.7290291 · Cited by 301
Cellular machineries for chromosomal DNA repair
Peterson, C. L., & Côté, J. (2004) · Genes & Development · doi:10.1101/gad.1182704 · Cited by 285
“Recently, several groups have demonstrated that the 90-amino acid BRCT (BRCA1 COOHterminal) domain is a novel phosphoserine/phosphothreonine-binding module specific for ATM/ATR targets (Manke et al. 2003; Rodriguez et al. 2003; Yu et al. 2003).”
BackgroundBRCA1 ubiquitinates its phosphorylation-dependent binding partner CtIP
Yu, X., Fu, S., Lai, M., Baer, R., & Chen, J. (2006) · Genes & Development · doi:10.1101/gad.1431006 · Cited by 284
“…Baer and Ludwig 2002; Chen et al. 2002; Xia et al. 2003; Sato et al. 2004; Starita et al. 2004, 2005; Kleiman et al. 2005), while the BRCT domain has recently been demonstrated to be a phospho-protein interaction domain (Manke et al. 2003; Rodriguez et al. 2003; Yu et al. 2003; Glover et al. 2004).”
BackgroundSelf-citationPhospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response
Reinhardt, H. C., & Yaffe, M. B. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3640 · Cited by 266
Clapperton, J. A., Manke, I. A., Lowery, D. M., Ho, T., Haire, L. F., Yaffe, M. B., & Smerdon, S. J. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb775 · Cited by 250
Saccharomyces cerevisiae Rad9 acts as a Mec1 adaptor to allow Rad53 activation
Sweeney, F. D., Yang, F., Chi, A., Shabanowitz, J., Hunt, D. F., & Durocher, D. (2005) · Current Biology · doi:10.1016/j.cub.2005.06.063 · Cited by 237
The role of BRCA1 in DNA damage response
Wu, J., Lu, L.-Y., & Yu, X. (2010) · Protein & Cell · doi:10.1007/s13238-010-0010-5 · Cited by 235
“The C-terminal BRCT domain of BRCA1 is a phospho-protein binding domain (Manke et al., 2003; Rodriguez et al., 2003; Yu et al., 2003), which is also required for BRCA1’s translocation and accumulation at DNA damage sites (discussed later).”
BackgroundSelf-citationStructural basis of phosphopeptide recognition by the BRCT domain of BRCA1
Williams, R. S., Lee, M. S., Hau, D. D., & Glover, J. N. M. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb776 · Cited by 230
The role of the non‐homologous end‐joining pathway in lymphocyte development
Rooney, S., Chaudhuri, J., & Alt, F. W. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00165.x · Cited by 224
Role of DNA–PK in the cellular response to DNA double-strand breaks
Burma, S., & Chen, D. J. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.021 · Cited by 219
Interactions between BRCT repeats and phosphoproteins: tangled up in two
Glover, J. N. M., Williams, R. S., & Lee, M. S. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.09.010 · Cited by 211
“The BRCT repeats of MDC1 bind preferentially to peptides containing the motif pSer-Ile-Glu-Tyr (in which the phospho-serine, glutamic acid and tyrosine residues are the primary binding determinants) [ 44 ].”
InfluentialNakamura, T. M., Du, L.-L., Redon, C., & Russell, P. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6215-6230.2004 · Cited by 195
“It will be interesting to test if the BRCT domains mediate direct binding to -H2A, given recent evidence that BRCT domains are phosphopeptide-binding modules (45, 70, 90).”
BackgroundTUTT, A. N. J., LORD, C. J., MCCABE, N., FARMER, H., TURNER, N., MARTIN, N. M., JACKSON, S. P., SMITH, G. C. M., & ASHWORTH, A. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.012 · Cited by 196
“In BRCA1, the RING domain has been implicated in ubiquitin-mediated protein degradation, and the pair of carboxy-terminal BRCT repeats comprise phosphopeptide-binding domains (Kerr and Ashworth 2001; Rodriguez et al. 2003).”
BackgroundIsmail, I. H., Wadhra, T. I., & Hammarsten, O. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1169 · Cited by 187
The Human Rap1 Protein Complex and Modulation of Telomere Length
O'Connor, M. S., Safari, A., Liu, D., Qin, J., & Songyang, Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312913200 · Cited by 182
Self-citationMark, W.-Y., Liao, J. C. C., Lu, Y., Ayed, A., Laister, R., Szymczyna, B., Chakrabartty, A., & Arrowsmith, C. H. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.10.045 · Cited by 177
Structure of the BRCT Repeats of BRCA1 Bound to a BACH1 Phosphopeptide
Shiozaki, E. N., Gu, L., Yan, N., & Shi, Y. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00238-2 · Cited by 174
Microcephalin Is a DNA Damage Response Protein Involved in Regulation of CHK1 and BRCA1
Xu, X., Lee, J., & Stern, D. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400139200 · Cited by 171
Lee, M. S., Green, R., Marsillac, S. M., Coquelle, N., Williams, R. S., Yeung, T., Foo, D., Hau, D. D., Hui, B., Monteiro, A. N. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4563 · Cited by 168
BRCT domains: Easy as one, two, three
Leung, C. C. Y., & Glover, J. N. M. (2011) · Cell Cycle · doi:10.4161/cc.10.15.16312 · Cited by 167
The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response
Li, M., Lu, L.-Y., Yang, C.-Y., Wang, S., & Yu, X. (2013) · Genes & Development · doi:10.1101/gad.226357.113 · Cited by 164
“However, based on the peptide screening, not all of the FHA and BRCT domains have high affinity to phospho-proteins (Durocher et al. 2000; Rodriguez et al. 2003).”
BackgroundSelf-citationStructural basis of homologous recombination
Sun, Y., McCorvie, T. J., Yates, L. A., & Zhang, X. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03365-1 · Cited by 162
Drouet, J., Delteil, C., Lefrançois, J., Concannon, P., Salles, B., & Calsou, P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410746200 · Cited by 154
14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response
Mohammad, D. H., & Yaffe, M. B. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.04.004 · Cited by 152
“The phospho-ligand binding specificity of domains that localize to foci generally overlap with the ATM kinase motif, such that these domains can bind to ATM substrates [6-9].”
Structural and Functional Interaction between the Human DNA Repair Proteins DNA Ligase IV and XRCC4
Wu, P.-Y., Frit, P., Meesala, S., Dauvillier, S., Modesti, M., Andres, S. N., Huang, Y., Sekiguchi, J., Calsou, P., Salles, B., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01895-08 · Cited by 149
“The BRCT repeat of human LigIV has been shown to similarly bind phosphoserine-containing peptides in vitro (36, 43).”
BackgroundCCDC98 targets BRCA1 to DNA damage sites
Liu, Z., Wu, J., & Yu, X. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1279 · Cited by 148
Self-citationLiu, K., Luo, Y., Lin, F.-T., & Lin, W.-C. (2004) · Genes & Development · doi:10.1101/gad.1180204 · Cited by 147
“E2F1 is phosphorylated by ATM (ataxia telangiectasia mutated; Lin et al. 2001) and Chk2 (Stevens et al. 2003) during DNA damage.”
BackgroundInfluentialHistone Ubiquitination Associates with BRCA1-Dependent DNA Damage Response
Wu, J., Huen, M. S. Y., Lu, L.-Y., Ye, L., Dou, Y., Ljungman, M., Chen, J., & Yu, X. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01302-08 · Cited by 145
“ing domain (34, 44, 66), is required for BRCA1’s translocation”
BackgroundSelf-citationBRCA1 Affects Lipid Synthesis through Its Interaction with Acetyl-CoA Carboxylase
Moreau, K., Dizin, E., Ray, H., Luquain, C., Lefai, E., Foufelle, F., Billaud, M., Lenoir, G. M., & Venezia, N. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m504652200 · Cited by 137
A guide for functional analysis of BRCA1 variants of uncertain significance
Millot, G. A., Carvalho, M. A., Caputo, S. M., Vreeswijk, M. P. G., Brown, M. A., Webb, M., Rouleau, E., Neuhausen, S. L., Hansen, T. V. O., Galli, A., et al. (2012) · Human Mutation · doi:10.1002/humu.22150 · Cited by 126
“The BRCT domains in BRCA1 interact with phosphorylated protein targets containing the sequence pSer-x-x-Phe [Botuyan et al., 2004; Clapperton et al., 2004; Rodriguez et al., 2003; Shiozaki et al., 2004; Williams et al., 2004; Yu et al., 2003] (Fig.”
BackgroundLee, M. S., Edwards, R. A., Thede, G. L., & Glover, J. N. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500273200 · Cited by 127
BRCA1 gene: function and deficiency
Takaoka, M., & Miki, Y. (2017) · International Journal of Clinical Oncology · doi:10.1007/s10147-017-1182-2 · Cited by 141
Pryde, F., Khalili, S., Robertson, K., Selfridge, J., Ritchie, A.-M., Melton, D. W., Jullien, D., & Adachi, Y. (2005) · Journal of Cell Science · doi:10.1242/jcs.02336 · Cited by 127
“BRCT motifs mediate protein-protein interactions and in some cases bind specifically to phosphorylated targets (Dulic et al., 2001; Grawunder et al., 1998; Manke et al., 2003; Rodriguez et al., 2003; Soulier and Lowndes, 1999; Yu et al., 2003).”
BackgroundEarly events in the mammalian response to DNA double-strand breaks
Riches, L. C., Lynch, A. M., & Gooderham, N. J. (2008) · Mutagenesis · doi:10.1093/mutage/gen039 · Cited by 123
Carvalho, M. A., Marsillac, S. M., Karchin, R., Manoukian, S., Grist, S. A., Swaby, R. F., Ürményi, T. P., Rondinelli, E., Silva, R., Gayol, L., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3297 · Cited by 130
XLF regulates filament architecture of the XRCC4.ligase IV complex
Hammel, M., Yu, Y., Fang, S., Lees-Miller, S. P., & Tainer, J. A. (2010) · Structure · doi:10.1016/j.str.2010.09.009 · Cited by 116
Nowsheen, S., Aziz, K., Aziz, A., Deng, M., Qin, B., Luo, K., Jeganathan, K. B., Zhang, H., Liu, T., Yu, J., et al. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0071-x · Cited by 121
“Thus, ATM-mediated phosphorylation of L3MBTL2 promotes its interaction with MDC1 and recruits it to DSBs. MDC1 contains tandem BRCT domains and a FHA domain that recognize phosphorylated serine/threonine (pS/T) containing motifs 4, 26, 27 .”
The cellular response to DNA damage: A focus on MDC1 and its interacting proteins
Coster, G., & Goldberg, M. (2010) · Nucleus · doi:10.4161/nucl.1.2.11176 · Cited by 122
Kumaraswamy, E., & Shiekhattar, R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00961-07 · Cited by 110
“Recent evidence suggests that the BRCT domain represents a new class of modules that mediate phosphorylationdependent protein-protein interactions (29).”
BackgroundTopoisomerase IIα controls the decatenation checkpoint
Luo, K., Yuan, J., Chen, J., & Lou, Z. (2009) · Nature Cell Biology · doi:10.1038/ncb1828 · Cited by 108
“The MDC1 BRCT domain is predicted to preferentially bind a phospho-pSer(Thr)xxPhe moti”
Self-citationA CDK‐catalysed regulatory phosphorylation for formation of the DNA replication complex Sld2–Dpb11
Tak, Y., Tanaka, Y., Endo, S., Kamimura, Y., & Araki, H. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601075 · Cited by 132
“This is consistent with previous observations in various BRCT domains: some of the amino-acid residues following a phosphorylated serine/ threonine play an important role in binding BRCT domains (Manke et al, 2003; Rodriguez et al, 2003).”
BackgroundResultCharting the Landscape of Tandem BRCT Domain–Mediated Protein Interactions
Woods, N. T., Mesquita, R. D., Sweet, M., Carvalho, M. A., Li, X., Liu, Y., Nguyen, H., Thomas, C. E., Iversen, E. S., Marsillac, S., et al. (2012) · Science Signaling · doi:10.1126/scisignal.2002255 · Cited by 105
“Several BRCT domains recognize linear motifs phosphorylated by kinases that are activated by DNA damage (8, 9, 17).”
BackgroundInfluentialAssessment of functional effects of unclassified genetic variants
Couch, F. J., Rasmussen, L. J., Hofstra, R., Monteiro, A. N. A., Greenblatt, M. S., de Wind, N., & for the IARC Unclassified Genetic Variants Working Group (2008) · Human Mutation · doi:10.1002/humu.20899 · Cited by 105
Kotoglou, P., Kalaitzakis, A., Vezyraki, P., Tzavaras, T., Michalis, L. K., Dantzer, F., Jung, J. U., & Angelidis, C. (2009) · Cell Stress and Chaperones · doi:10.1007/s12192-008-0093-6 · Cited by 102
“This finding was very important given that similar domains possess some proteins participating in ssDNA repairing systems, among them, XRCC1, DNA ligase III, and BRCA-1 ( Rodriguez et al. 2003 ).”
BackgroundThe evolution of meiosis: Recruitment and modification of somatic DNA-repair proteins
Marcon, E., & Møens, P. B. (2005) · BioEssays · doi:10.1002/bies.20264 · Cited by 113
“BRCA1 and BRCA2, in addition to being regulated by phosphorylation, preferentially bind phosphopeptides.((86)) Thus, the phosphorylation of BRCA1 is determined not only by its activity but also by the phosphorylation state of its interacting partners.”
BackgroundMDC1: The art of keeping things in focus
Jungmichel, S., & Stucki, M. (2010) · Chromosoma · doi:10.1007/s00412-010-0266-9 · Cited by 120
“Since BRCT repeats can act as phosphopeptide-binding domains, oriented phosphopeptide library screening was used to define the optimal phosphopeptide binding motif for the MDC1 BRCT tandem domain ( Rodriguez et al. 2003; Stucki et al. 2005).”
BackgroundMethodBRCA1 Promotes Induction of ssDNA by Ionizing Radiation
Schlegel, B. P., Jodelka, F. M., & Nunez, R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3209 · Cited by 101
Structural Basis of BACH1 Phosphopeptide Recognition by BRCA1 Tandem BRCT Domains
Botuyan, M. V., Nominé, Y., Yu, X., Juranić, N., Macura, S. I., Chen, J., & Mer, G. (2004) · Structure · doi:10.1016/j.str.2004.06.002 · Cited by 106
“Our study of BRCA1-BRCT/BACH1p complex will be relevant in understanding the mode of action of other proteins, such as MDC1, BARD1, PTIP, Rad9, and 53BP1, all of which contain tandem BRCT domains and all of which bind phosphopeptides (Manke et al., 2003; Rodriguez et al., 2003; Yu et al., 2003).”
BackgroundInfluentialSelf-citationCtIP: A DNA damage response protein at the intersection of DNA metabolism
Makharashvili, N., & Paull, T. T. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.04.016 · Cited by 112
Growth factor pleiotropy is controlled by a receptor Tyr/Ser motif that acts as a binary switch
Guthridge, M. A., Powell, J. A., Barry, E. F., Stomski, F. C., McClure, B. J., Ramshaw, H. S., Felquer, F. A., Dottore, M., Thomas, D., To, B., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7600948 · Cited by 102
“…phosphothreonine-binding modules, including WW, forkhead-associated, polo-box and the BRCA1 COOH domains (Yaffe and Elia, 2001; Elia et al, 2003; Rodriguez et al, 2003), raises the possibility that receptor serine/threonine phosphorylation could also provide docking sites for the assembly of…”
BackgroundBACH1 is a DNA repair protein supporting BRCA1 damage response
Peng, M., Litman, R., Jin, Z., Fong, G., & Cantor, S. B. (2006) · Oncogene · doi:10.1038/sj.onc.1209257 · Cited by 88
“This binding was shown to be dependent on BACH1 phosphorylation at serine 990 and critical for BRCA1 to mediate the G2/M checkpoint (Rodriguez et al., 2003; Yu et al., 2003).”
BackgroundThe BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis
Jansen, J. G. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki189 · Cited by 85
BARD1 induces apoptosis by catalysing phosphorylation of p53 by DNA-damage response kinase
Féki, A., Jefford, C. E., Berardi, P., Wu, J., Cartier, L., Krause, K., & Irminger‐Finger, I. (2005) · Oncogene · doi:10.1038/sj.onc.1208491 · Cited by 94
“It was shown before that BRCT domains, a protein motif also present in BARD1 and BRCA1, have phospho-epitope-binding capacities (Rodriguez et al., 2003).”
BackgroundNew concepts on BARD1: Regulator of BRCA pathways and beyond
Irminger‐Finger, I., Ratajska, M., & Pilyugin, M. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.12.008 · Cited by 85
Phosphorylation and Regulation of DNA Ligase IV Stability by DNA-dependent Protein Kinase
Wang, Y.-G., Nnakwe, C., Lane, W. S., Modesti, M., & Frank, K. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401217200 · Cited by 80
BRCA1 tumor suppressor network: focusing on its tail
Wang, B. (2012) · Cell & Bioscience · doi:10.1186/2045-3701-2-6 · Cited by 78
“BRCA1 forms three different complexes through its C-terminus BRCT domains The BRCT domains of BRCA1 constitute a phosphopeptide binding domain recognizing a phospho-SPxF motif (S, serine; P, proline; × varies; F, phenylalanine) [28-30].”
BackgroundPoly-ADP ribosylation in DNA damage response and cancer therapy
Hou, W., Chen, S.-H., & Yu, X. (2017) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2017.09.004 · Cited by 87
Self-citationWu, Q., Paul, A., Su, D., Mehmood, S., Foo, T. K., Ochi, T., Bunting, E. L., Xia, B., Robinson, C. V., Wang, B., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2015.12.017 · Cited by 76
“, 2004) (Figure S3C), in which the tyrosine residue (Y) at 3 position (phosphorylated serine in pSxxF motif as 0 position) and negatively charged residues glutamic acid (E) or aspartic acid (D) at 2 position were shown more favored for interaction with BRCA1 BRCT domains (Manke et al., 2003; Rodriguez et al., 2003).”
BackgroundInfluentialThe DNA-polymerase-X family: controllers of DNA quality?
Ramadan, K., Shevelev, I., & Hübscher, U. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1530 · Cited by 90
“ATM and ATR proteins are signal-transducing kinases that are involved in DNA-damage-checkpoint pathway”
BackgroundUsui, T., Foster, S. S., & Petrini, J. H. J. (2009) · Molecular Cell · doi:10.1016/j.molcel.2008.12.022 · Cited by 74
“The consensus phosphopeptide-binding site for the Rad9 BRCT domain is pS/pT-[YILQP]-I-I (Rodriguez et al., 2003).”
BackgroundSIRT1 Shows No Substrate Specificity in Vitro
Blander, G., Olejnik, J., Krzymanska-Olejnik, E., McDonagh, T., Haigis, M., Yaffe, M. B., & Guarente, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414080200 · Cited by 72
Viral Transport of DNA Damage That Mimics a Stalled Replication Fork
Jurvansuu, J., Raj, K., Stasiak, A., & Beard, P. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.569-580.2005 · Cited by 71
Sturdy, A., Naseem, R., & Webb, M. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.05.005 · Cited by 74
The interplay of Fanconi anemia proteins in the DNA damage response
Wang, X., & D’Andrea, A. D. (2004) · DNA repair · doi:10.1016/j.dnarep.2004.04.005 · Cited by 81
Selectivity and promiscuity in the interaction network mediated by protein recognition modules
Castagnoli, L., Costantini, A., Dall’Armi, C., Gonfloni, S., Montecchi‐Palazzi, L., Panni, S., Paoluzi, S., Santonico, E., & Cesareni, G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.116 · Cited by 86
Regulation of BRCA1, BRCA2 and BARD1 intracellular trafficking
Henderson, B. R. (2005) · BioEssays · doi:10.1002/bies.20277 · Cited by 82
Baldock, R. A., Day, M., Wilkinson, O. J., Cloney, R., Jeggo, P. A., Oliver, A. W., Watts, F. Z., & Pearl, L. H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.074 · Cited by 74
“53BP1-BRCT2 Binds gH2AX In Vitro Comparison of the tandem BRCT domains of 53BP1 with those of MDC1 (Rodriguez et al., 2003; Stucki et al., 2005) and Crb2 (Kilkenny et al., 2008) shows strong conservation of residues orts 13, 2081–2089, December 15, 2015 ª2015 The Authors 2081 (legend continued on…”
BackgroundMolecular Basis of BACH1/FANCJ Recognition by TopBP1 in DNA Replication Checkpoint Control
Leung, C. C. Y., Gong, Z., Chen, J., & Glover, J. N. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.189555 · Cited by 71
Self-citationPlant phosphopeptide-binding proteins as signaling mediators
Gökirmak, T., Paul, A., & Ferl, R. J. (2010) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2010.06.001 · Cited by 71
Eliezer, Y., Argaman, L., Rhie, A., Doherty, A. J., & Goldberg, M. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807375200 · Cited by 65
Nick McElhinny, S. A., & Ramsden, D. A. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00160.x · Cited by 64
Au, W. W. Y., & Henderson, B. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408879200 · Cited by 62
Sankaran, S., Starita, L. M., Simons, A. M., & Parvin, J. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4430 · Cited by 69
“Silver-stained gel containing 1 pmol BRCA1(1-1,863)/BARD1(1-770) (lane 1) and BRCA1(1-1,863)/ BARD1(1-292) at 0.”
BackgroundMethodResultInfluentialGlover, J. N. M. (2006) · Familial Cancer · doi:10.1007/s10689-005-2579-z · Cited by 57
“Indeed, a number of other BRCTcontaining proteins, including PTIP, 53BP1, and BARD1, have now been shown to have phosphopeptide binding activity [15, 16, 20].”
BackgroundShen, Y., & Tong, L. (2008) · Biochemistry · doi:10.1021/bi800314m · Cited by 56
Impact of BRCA1 BRCT Domain Missense Substitutions on Phosphopeptide Recognition
Coquelle, N., Green, R., & Glover, J. N. M. (2011) · Biochemistry · doi:10.1021/bi2003795 · Cited by 58
Liu, Y., Cussiol, J. R. R., Dibitetto, D., Sims, J. R., Twayana, S., Weiss, R. S., Freire, R., Marini, F., Pellicioli, A., & Smolka, M. B. (2017) · The Journal of Cell Biology · doi:10.1083/jcb.201607031 · Cited by 65
“TOP BP1Dpb11 is comprised of multiple BRCA1 C terminus (BRCT) domains (nine in humans and four in yeast), which are protein-interacting modules that often recognize phosphorylated motifs (Manke et al., 2003; Rodriguez et al., 2003; Yu et al., 2003).”
BackgroundLaufer, M., Nandula, S. V., Modi, A. P., Wang, S., Jasin, M., Murty, V. V. V. S., Ludwig, T., & Baer, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705198200 · Cited by 55
Nakanishi, M., Ozaki, T., Yamamoto, H., Hanamoto, T., Kikuchi, H., Furuya, K., Asaka, M., Delia, D., & Nakagawara, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611412200 · Cited by 61
A common SNP of MCPH1 is associated with cranial volume variation in Chinese population
Wang, J.-K., Li, Y., & Su, B. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn021 · Cited by 54
Sadeghi, F., Asgari, M., Matloubi, M., Ranjbar, M., Yousefi, N. K., Azari, T., & Zaki‐Dizaji, M. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00133-5 · Cited by 66
“BRCA2 Plk USP21 Cyclin D1 A-CDK2 RAD51 Double strand break PALB2 BRCA2 RAD51 RAD51 loading & RAD51dependent HR DNA ligase & DNA synthesis CHK2 Strand invasion ATM Nbs1 DSB resection BRCA1 Abraxas RAP80 H2AX Regulation of RAD51-BRCA2 complex formation RAD50Mre11 RNF8 MDC1 Nbs1RAD50Mre11 Nbs1RAD50Mre11 BRCA1 BRCA1 BRCA1…”
BackgroundBRCT domains: A little more than kin, and less than kind
Gerloff, D. L., Woods, N. T., Farago, A. A., & Monteiro, Á. N. A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.05.005 · Cited by 54
Toward Classification of BRCA1 Missense Variants Using a Biophysical Approach
Rowling, P. J. E., Cook, R. S., & Itzhaki, L. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088922 · Cited by 48
Early Events in the DNA Damage Response
Ward, I. M., & Chen, J. (2004) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(04)63001-8 · Cited by 59
Self-citationBRCT Domains: phosphopeptide binding and signaling modules
María, C. (2008) · Frontiers in bioscience · doi:10.2741/3125 · Cited by 56
“Recent work from several laboratories has indicated that BRCT repeats can also function as phosphopeptide-binding modules, shedding new light on how signals may be transduced from protein kinases through BRCT containing proteins (13,14,33).”
InfluentialRegulating BRCA1 protein stability by cathepsin S-mediated ubiquitin degradation
Kim, S., Jin, H. K., Seo, H. R., Lee, H. J., & Lee, Y. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0153-0 · Cited by 51
Metadata
- Authors
- Rodriguez, M., Yu, X., Chen, J., & Songyang, Z.
- Affiliations
- Baylor College of Medicine (US)
- Mayo Clinic (US)
- Corresponding author
- Songyang, Zhou
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 278
- Issue
- 52
- Pages
- 52914-52918
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2105395542
- Cited by
- 234
- References
- 40
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 6 · 2023: 12 · 2022: 2 · 2021: 4 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 4 · 2016: 7 · 2015: 10 · 2014: 3 · 2013: 11 · 2012: 15
- FWCI
- 8.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6144 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (GM569209)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- BRCA1, BRCT domain, phosphopeptide binding, protein phosphorylation, protein-protein interaction, DNA damage response, MDC1, BARD1, DNA ligase IV, BACH1, Rad9, signaling complex assembly
- MeSH terms
- DNA Ligase ATP, Carrier Proteins, DNA Damage, DNA Repair, DNA-Binding Proteins, Dose-Response Relationship, Drug, Dose-Response Relationship, Radiation, HeLa Cells, Humans, Microscopy, Fluorescence, Mitosis, Mutation, Nuclear Proteins, Peptides, Phosphorylation, Phosphoserine, DNA Ligases, Protein Binding, Transcription Factors, Signal Transduction, Trans-Activators, Gene Library, G2 Phase, Protein Structure, Tertiary, Cell Cycle Proteins, BRCA1 Protein, Genes, BRCA1, Amino Acid Motifs, Tumor Suppressor Proteins, RNA, Small Interfering, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing, Basic-Leucine Zipper Transcription Factors, Fanconi Anemia Complementation Group Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.